Topic Archives: Arch Therapeutics (ARTH)

Arch Therapeutics ($ARTH) has withdrawn its 501(k) device-approval marketing application with the FDA. I spoke with CEO Terrence Norchi, MD, MBA, by phone this morning for clarification and to ask a few questions. Norchi explained that he regards Arch’s relationship with the FDA as “good and friendly” and wants to be cautious not to jeopardize […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Thanks to you I’m much obliged Such a […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, choses his own topics, and his words and opinions are his own. All of his previous articles and most recent comments can be found on his Stock Gumshoe page.] “I have seen you shake And […]

[Ed. Note: Dr. KSS is an MD and PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and recent comments here.] You’re probably getting it right by now—writing “2016” and not “2015.” […]

This is the first ticker specific discussion…..if it works, there may be many others. The aim is to have a chronological knowledge diary. If your comment is about ANYTHING other than $ARTH…please DONT post it here. **Please note that this post has been closed to further comment. The discussion on ARTH has moved over to […]

[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars!  You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]

In his tearjerker “Sisters of Mercy,” Leonard Cohen sings, I’ve been where you’re hanging and think I can see how you’re pinned. Although I am less inclined to bash the FDA than many, it has recently let modern medical practice place many patients in an undesirable situation. What if there was a very powerful drug, […]

Comments

  • Travis Johnson, Stock Gumshoe

    I've written about that one a bunch of times (https://www.stockgumshoe.com/tag/insg/) -- I speculated last year that it ...

  • Avatar

    Hi I did a lot of searching and I fully agree with you on AKTS. On a totally different note ... do you have any thou...

  • Travis Johnson, Stock Gumshoe

    We covered that one here: https://www.stockgumshoe.com/reviews/strategic-trends-investor/the-next-tech-giant-whats-fessl...

  • Avatar

    I did a little research not only tower or what have you, I looked at what company was already pumping out 5G equipment ...

  • Travis Johnson, Stock Gumshoe

    Just means some note holders, probably the "rescue" backers from a couple years ago, have agreed to convert some of that...

  • Avatar

    i bought a couple hundred shares of INSG at $4.50 /share in mid November... and just now realized that I've doubled my ...

  • Avatar

    INSG $9+ AND RISING AFTER HOURS...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info